These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 12661779)
1. Quantification of follicle stimulating hormone (follitropin alfa): is in vivo bioassay still relevant in the recombinant age? Driebergen R; Baer G Curr Med Res Opin; 2003; 19(1):41-6. PubMed ID: 12661779 [TBL] [Abstract][Full Text] [Related]
2. Outcome from consecutive assisted reproduction cycles in patients treated with recombinant follitropin alfa filled-by-bioassay and those treated with recombinant follitropin alfa filled-by-mass. Balasch J; Fábregues F; Peñarrubia J; Creus M; Manau D; Vidal E; Casamitjana R; Vanrell JA Reprod Biomed Online; 2004 Apr; 8(4):408-13. PubMed ID: 15149563 [TBL] [Abstract][Full Text] [Related]
3. Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment. Agostinetto R Reprod Biol Endocrinol; 2009 May; 7():48. PubMed ID: 19450267 [TBL] [Abstract][Full Text] [Related]
4. Routine use of r-hFSH follitropin alfa filled-by-mass for follicular development for IVF: a large multicentre observational study in the UK. Lass A; McVeigh E; Reprod Biomed Online; 2004 Dec; 9(6):604-10. PubMed ID: 15670403 [TBL] [Abstract][Full Text] [Related]
5. Follicle-stimulating hormone in clinical practice: an update. Daya S Treat Endocrinol; 2004; 3(3):161-71. PubMed ID: 16026112 [TBL] [Abstract][Full Text] [Related]
6. Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH. Bassett RM; Driebergen R Reprod Biomed Online; 2005 Feb; 10(2):169-77. PubMed ID: 15823219 [TBL] [Abstract][Full Text] [Related]
7. In-vivo biological activity and glycosylation analysis of a biosimilar recombinant human follicle-stimulating hormone product (Bemfola) compared with its reference medicinal product (GONAL-f). Mastrangeli R; Satwekar A; Cutillo F; Ciampolillo C; Palinsky W; Longobardi S PLoS One; 2017; 12(9):e0184139. PubMed ID: 28880909 [TBL] [Abstract][Full Text] [Related]
11. Outcomes of new quality standards of follitropin alfa on ovarian stimulation: meta-analysis of previous studies. Saz-Parkinson Z; López-Cuadrado T; Bouza C; Amate JM BioDrugs; 2009; 23(1):37-42. PubMed ID: 19344190 [TBL] [Abstract][Full Text] [Related]
12. Physicochemical methods for predicting the biological potency of recombinant follicle stimulating hormone: an international collaborative study of isoelectric focusing and capillary zone electrophoresis. Storring PL; Gaines Das RE; Mulders JW; Halder M Biologicals; 2002 Sep; 30(3):217-34. PubMed ID: 12217346 [TBL] [Abstract][Full Text] [Related]
13. A comparison between follitropin alpha filled by mass and follitropin alpha filled by bioassay in the same egg donors. Martinez G; Sanguineti F; Sepulveda J; Dorey J; Arici A; Patrizio P Reprod Biomed Online; 2007 Jan; 14(1):26-8. PubMed ID: 17207327 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders. Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J; Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754 [TBL] [Abstract][Full Text] [Related]
15. A pilot study on potency determination of human follicle-stimulating hormone: a comparison between reversed-phase high-performance liquid chromatography method and the in vivo bioassay. Almeida BE; Oliveira JE; Damiani R; Dalmora SL; Bartolini P; Ribela MT J Pharm Biomed Anal; 2011 Mar; 54(4):681-6. PubMed ID: 21093191 [TBL] [Abstract][Full Text] [Related]
16. XM17 Follitropin Alfa (Ovaleap(®)): A Review in Reproductive Endocrine Disorders. Hoy SM BioDrugs; 2016 Aug; 30(4):379-86. PubMed ID: 27342604 [TBL] [Abstract][Full Text] [Related]
17. Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap Winstel R; Wieland J; Gertz B; Mueller A; Allgaier H Drugs R D; 2017 Jun; 17(2):305-312. PubMed ID: 28386738 [TBL] [Abstract][Full Text] [Related]
18. Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART). Strowitzki T; Kuczynski W; Mueller A; Bias P Reprod Biol Endocrinol; 2016 Jan; 14():1. PubMed ID: 26733057 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study. Strowitzki T; Kuczynski W; Mueller A; Bias P Reprod Biol Endocrinol; 2016 Jun; 14(1):31. PubMed ID: 27287439 [TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection. The French Multicentre Trialists. Frydman R; Howles CM; Truong F Hum Reprod; 2000 Mar; 15(3):520-5. PubMed ID: 10686190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]